Prophylactic Evaluation of a Nipah Virus Monoclonal Antibody Medical Countermeasure

Project: Other project

Project Details

StatusActive
Effective start/end date9/27/221/1/24

Funding

  • Mapp Biopharmaceutical Inc: $762,425.00